(19)
(11) EP 1 601 782 A2

(12)

(88) Date of publication A3:
13.01.2005

(43) Date of publication:
07.12.2005 Bulletin 2005/49

(21) Application number: 03772262.6

(22) Date of filing: 25.10.2003
(51) International Patent Classification (IPC)7C12Q 1/44, C12Q 1/68, A61K 38/17, A61K 48/00, A61P 25/00, A61P 9/00, A61P 15/00, A61P 13/00, A61P 3/00
(86) International application number:
PCT/EP2003/011883
(87) International publication number:
WO 2004/042077 (21.05.2004 Gazette 2004/21)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 08.11.2002 EP 02024999

(71) Applicant: Bayer HealthCare AG
51368 Leverkusen (DE)

(72) Inventors:
  • GOLZ, Stefan
    45326 Essen (DE)
  • BRÜGGEMEIER, Ulf
    42799 Leichlingen (DE)
  • GEERTS, Andreas
    42113 Wuppertal (DE)

   


(54) DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 8B (PDE8B)